文章
醫療新知 > 丹麥人工卵巢新科技 可望協助癌癒婦女懷孕  / Artificial ovaries could help young cancer patients preserve their fertility, and this is a game-changer

丹麥人工卵巢新科技 可望協助癌癒婦女懷孕  / Artificial ovaries could help young cancer patients preserve their fertility, and this is a game-changer

05-07-2018

丹麥人工卵巢新科技 可望協助癌癒婦女懷孕 

(法新社資料圖片)

 

丹麥科學加宣布研發人工卵巢新技術,將來可望有助曾接受化療、放射治療等婦女重拾生育能力。

現有醫學技術主要有兩種方法,助有婦女保留生育能力。第一種是選擇冷藏卵子,待治癒癌症後,再用人工授孕方法生育。另一方法是移除和冷藏部分卵巢組織,治病後再植回病人體內。不過,由於原有卵巢組織可能殘留癌細胞,因此第二種方法風險較高亦較少用。

哥本哈根國家醫院(Rigshospitalet)生殖生物學實驗室博士後研究員波爾什(Susanne Pors)及其他專家研究人工卵巢技術。研究人員先抽取女病人自身或由別人捐贈的卵巢組織,再用化學方法清除當中所有細胞,以杜絕癌細胞殘留風險,只餘下蛋白質和膠原蛋白組成的「去細胞支架」(decellularized scaffold),亦即人工卵巢。

專家再把預先冷藏的病人卵泡(follicle)「種回」人工卵巢。由於卵泡在人類胚胎時期已形成,亦有保護膜保護,因此可確保癌細胞不能入侵。專家以老鼠體內所做試驗顯示,人工卵巢能夠支持卵泡生長。

研究結果周一(2日)在西班牙巴塞隆拿舉行的歐洲生殖醫學會年度會議上發表,專家強調這種技術尚需驗證。

(美國有線新聞網絡/英國廣播公司)

***********************************************************************************************************************************

Artificial ovaries could help young cancer patients preserve their fertility, and this is a game-changer

 

While many people are familiar with women freezing their eggs to extend or preserve their reproductive abilities, a new fertility method could soon offer a new option. CNN reports that Danish researchers have created an artificial ovary that may preserve fertility for young cancer patients. Ovaries produce eggs, and some cancer treatments damage the ovaries, which can lead to infertility. So these artificial ovaries could possibly help women treat their cancer without having the additional concern of losing the ability to have biological children.

The American Cancer Society notes that both chemotherapy and radiation therapies can damage the ovaries. Currently, women have the options of freezing eggs, embryos, or pieces of their ovaries, or undergoing infertility treatment after cancer as a way to conceive. But a team at the Laboratory of Reproductive Biology at the University Hospital of Copenhagen Rigshospitalet have created yet another option.

The researchers believed that they could bioengineer a “scaffold” of ovarian tissue that contains no cancer. Then, early-stage follicles could grow naturally into fully functional ovarian follicles on this scaffold. In the female body, ovarian follicles each contain one egg that matures during the menstrual cycle. The scientists were able to make the follicles grow on the scaffold, which could allow a woman with damaged ovaries to have children.

 

“This is the first time that isolated human follicles have survived in a decellularized human scaffold,” the authors of the study noted.

 

An artificial ovary may soon be possible, according to researchers who have engineered an ovarian “scaffold” on which early-stage cells can develop into functional follicles https://cnn.it/2MES1oQ

 

One of the authors, Dr. Susanne Pors, explained to CNN in an email how the artificial ovary would work in the real world. “The artificial ovary will consist of a scaffold (originating from the woman’s own tissue or from donated tissue) combined with her own follicles,” Pors wrote. “It is newly constructed, but biological.”

According to USA Today, the researchers presented their findings at the European Society of Human Reproduction and Embryology annual meeting on July 2nd. “We have now done the first important steps towards constructing a cancer-free ovary,” Pors said. “We have many more studies to do, but this is a proof-of-concept showing that human eggs can survive on a newly constructed scaffold.”

There is still much work to be done before these artificial ovaries can be used. And both USA Today and CNN noted that other scientists not involved in the study have expressed their uncertainty about whether or not these experimental ovaries will be successful. But if they are, the artificial ovaries could help extend the fertility of young female cancer patients who don’t want to give up the hope of having biological children.

 

 

疑難排解

會員註冊


或許你會想看
HER2乳癌既兇且惡:適當治療控病效果佳 更能保住生活質素
很多女士以為乳癌離自己很遠,但這種女性最常見癌症其實十分普遍,大約每14名女性便有一人會於75歲之前患上乳癌1 […]
慢性淋巴細胞白血病 (CLL) 口服標靶藥 助病人長時間穩定病情
王紹明醫生 中文大學內科及藥物治療學系名譽臨床副教授 「慢性淋巴細胞白血病 (Chronic lymphocy […]
中大全球首證血糖波動不穩的肥胖型糖尿病患者有較高患癌風險 並證實接受一類常用降血壓藥物的糖尿病患者患癌風險則較低
香港中文大學(中大)醫學院利用大數據研究糖尿病患者的患癌風險,首次獲得兩項重要發現。研究團隊發現患有糖尿病並有 […]
中大葉氏家族基金腫瘤學教授陳林教授就職演講「不苦口的良藥」
抗癌治療的副作用為患者帶來巨大的生理和心理壓力,肝膽胰癌症患者更經常因器官受損,比其他癌症患者較易出現相關副作 […]
中大與國際團隊領導肺癌研究 證實Lorlatinib可成為ALK陽性晚期非小細胞肺癌一線治療
香港中文大學(中大)醫學院莫樹錦教授與國際肺癌專家團隊早前針對帶有「間變性淋巴瘤激酶(ALK)基因變異」的晚期 […]
中大研發嶄新治療組合 帶領亞洲策略性抗擊膽管癌
中大研發嶄新治療組合 帶領亞洲策略性抗擊膽管癌 2022年8月8日 1 中大醫學院領導的一項多中心臨床研究發現 […]
新藥Dostarlimab給MMR缺損病人的新希望
新藥Dostarlimab給MMR缺損病人的新希望 [醫療新資訊] MMR缺損對人們有甚麼影響呢﹖為甚麼新藥D […]
【創新科研】中大研新型抗癌免疫療法及可彎曲手術鑽 全國挑戰杯共奪5獎
【創新科研】中大研新型抗癌免疫療法及可彎曲手術鑽 全國挑戰杯共奪5獎 ▲ 左起:病理解剖及細胞學系助理教授鄧銘 […]
芯片上的蠕蟲能視作癌症偵察器﹖
芯片上的蠕蟲能視作癌症偵察器﹖ [癌症資訊新聞] 根據《科學報告》學術期刊發表了一篇研究報告指,科學家利用秀麗 […]
基石藥業胃腸道間質瘤精準靶向藥(avapritinib)在香港正式上市 創新療法有望惠及更多患者
基石藥業胃腸道間質瘤精準靶向藥(avapritinib)在香港正式上市 創新療法有望惠及更多患者   在眾多癌 […]